Etoricoxib

依托考昔

Report date: 2026/04/09 20:00:21
NME

Base Information

Drug NameEtoricoxib
Drug Alias Name依他昔布Exxiv依托昔布EtoricoxibumArcoxia +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenase-2 inhibitors
TargetsCyclooxygenase-2
Therapy Area/IndicationsLow Back PainPainPain, Postoperative +[22] 
Global Approved IndicationsDysmenorrheaOsteoarthritisArthritis, Gouty +[5] 
Approved Indications in ChinaDysmenorrheaOsteoarthritisArthritis, Gouty
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date2002/04/15
Country/TerritorySingaporeTurkeyNorway +[8] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMerck & Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesMerck Sharp & Dohme （Australia） Pty LtdMerck Sharp & Dohme CorpMansoura University
Inactive CompaniesLudwig Maximilians University Of MunichC4pain ApsX-Pert Med Gmbh +[10] 
Active IndicationsDysmenorrheaParkinson DiseaseOsteoarthritis +[6] 
Inactive IndicationsLow Back PainPainPain, Postoperative +[16] 

Other Information

ATC CodeM01AH05
Related LinksWikipediaDrugBankKEGG